Page 282 - DOENÇA MENINGOCÓCICA - VOLUME 2 - DIGITAL
P. 282

61) GOTSCHLICH, E. C.; GOLDSCHNEIDER, I. & ARTENSTEIN, M. Human immunity
                to the meningococcus. IV. Immunogenicity of group A and group C meningococcal
                polysaccharides in human volunteers, J. Exp. Med., New York, 124: 1367-1384, 1969.
                62) _______ Human immunity to the meningococcus. V. The effect of immunization with
                meningococcal group C polysaccharide on the carrier state. J. Exp. Med. New York, 129:
                1385-1395, 1969.

                63) LAPEYSONNIE, L.; VANDEKERKOVE, M. & CAUSSE, G. Epidémiologie et
                prophylaxie des meningococcies. Rev. Hyg. Med. soc., Paris, 17: 585-596, 1969.
                64) VANDEKERKOVE, M.; CAUSSE, G. & LAPEYSSONNIE, L. Diagnostic au laboratoire
                des méningococcies. Rev. Hyg. Med. soc., Paris, 17: 613-622, 1969.

                65) ARTENSTEIN, M. S.; GOLD, R.; ZIMMERLY, J. G.; WYLE, F. A.; SCHNEIDER, H. &
                HARKINS, C. Prevention of meningococcal disease by group C polysaccharide vaccine. N.
                Engl. J. Med., Boston, 282: 417-420, 1970.

                66) ARTENSTEIN, M. S. & GOLD, R. Current Status of prophylaxis of meningococcal
                disease. Milit. Med., Washington, 135: 735-739, 1970.

                67) DEVINE, L. F.; PIERCE, W. E.; FLOYD, T. M.; RHODE, S. L.; EDWARDS, E. A.; SIESS,
                E. E. & PECKINPAUGH, R. O. Evaluation of group C meningococcal polysaccharide
                vaccine in marine recruits, San Diego, California. Am. J. Epidemiol., YOWA, 91: 25-32,
                1970.
                68) FAUCON. R. & ZANNOTTI, P. La meningite cérébrospinale a Fès en 1966-1967. II
                - L’épidémie de Fès. D – Considérations épidémiologigues. Med. Trop., Marseille, 30: 329-
                340, 1970.
                69) FAUCON, R.; LEFEVRE, M.; MENARD, M. & MILLAN, J. La meningite cérébrospinale
                a Fès en 1966-1967. II - L’épidémie de Fès E. – Les porteurs de germes.  Med. Trop.,
                Marseille, 30: 472-476, 1970.
                70) FAUCON, R. & ZANNOTTI, P. La meningite cérébrospinale a Fès en 1966-1967. II -
                L’épidémie de Fès. F. - Prophylaxie. Med. Trop., Marseille, 30: 599-623, 1970.

                71) FINLAND, M. Revival of antibacterial immunization: meningococcal vaccines. Prove
                promising. J. Infect. Dis., Chicago, 121: 445-448, 1970 (editorials).

                72) HOLLIS, D. G.; WIGGINS, G. I.; WEAVER, R. E. & SCHUBERT, J. H. Current Status
                of lactose-fermenting Neisseria. Ann. N. Y. Acad. Sci., New York, 174: 444-449, 1970.
                73) KELLY, S.; STORM, E. & JUCKETT, D. Immunoglobulin M in meningococcemia, N.
                Y. State J. Med., New York, 1: 1298-1299, 1970.

                74) KENT, D. C. Epidemic meningococcal meningitis in Africa and the Middle East. Milit.
                Med., Washington, 135: 674-677, 1970,





                                                        280
   277   278   279   280   281   282   283   284   285   286   287